{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T03:14:48Z","timestamp":1790824488578,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study aims to evaluate and compare the dosimetric performance of tandem ovoid (TO) and tandem ring (TR) applicators in image-guided high-dose-rate intracavitary brachytherapy for cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Computed tomography datasets from 45 cervical cancer patients treated with either TO or TR applicators were analyzed. Dose-volume histograms were generated, and dose parameters for the target and organs at risk (OARs) were recorded for each insertion. Key dosimetric metrics, including doses to points A and B, D90 for the clinical target volume (CTV), and 2cc doses for the bladder, rectum, and sigmoid, were compared between the two applicator groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Dosimetric outcomes for target volumes showed no significant differences between TO and TR applicators, with comparable doses to point A (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.12), point B (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.43), and D90 CTV (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.10). Similarly, OAR doses for the bladder (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.10), rectum (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.15), and sigmoid (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.10) were statistically equivalent. However, TR applicators consistently delivered significantly higher doses to vaginal dose points (except anterior 5 mm points), highlighting a notable difference in dose distribution patterns.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>While both TO and TR applicators achieve similar dosimetric outcomes for the target and major OARs, the TR applicators are associated with significantly higher vaginal dose exposure. This distinction may have clinical implications, particularly for patients at risk of vaginal toxicity, and underscores the importance of applicator selection based on individual patient anatomy and treatment goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmp.jmp_171_24","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T09:00:20Z","timestamp":1741338020000},"page":"55-59","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Which Has a Superior Dosimetric Profile in Image-guided High-dose-rate Brachytherapy of Cervix \u2013 Tandem Ovoid or Tandem Ring Applicator?"],"prefix":"10.4103","volume":"50","author":[{"given":"Ramya","family":"Rangarajan","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Government Royapettah Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"key":"R1-20250324","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJM199605233342103","article-title":"Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection","volume":"334","author":"Scholes","year":"1996","journal-title":"N Engl J Med"},{"key":"R2-20250324","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American brachytherapy society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-20250324","first-page":"25","article-title":"Comparison of the ring applicatorand the Fletcher applicator for HDR gynaecologicalbrachytherapy","volume":"2","author":"Wolli","year":"1991","journal-title":"Selectron Brach J"},{"key":"R4-20250324","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0958-3947(95)00019-S","article-title":"High dose rate (HDR) brachytherapy technique:For carcinoma of uterine cervix using Nucletron applicators","volume":"20","author":"Nair","year":"1995","journal-title":"Med Dosim"},{"key":"R5-20250324","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.meddos.2008.06.003","article-title":"Dosimetric comparison of tandem and Ovoids versus tandem and ring for intracavitary gynecologic applications","volume":"33","author":"Levin","year":"2008","journal-title":"Med Dosim"},{"key":"R6-20250324","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/jrcr.jrcr_35_22","article-title":"The dosimetric comparison between tandem-ovoid and tandemring applicator in cervical cancer brachytherapy","volume":"13","author":"Prakash","year":"2022","journal-title":"J Radiat Cancer Res"},{"key":"R7-20250324","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rpor.2017.12.006","article-title":"Dosimetric evaluation of image based brachytherapy using tandem ovoid and tandem ring applicators","volume":"23","author":"Rangarajan","year":"2018","journal-title":"Rep Pract Oncol Radiother"},{"key":"R8-20250324","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2019.12.019","article-title":"Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy:Results from the EMBRACE I study","volume":"106","author":"Serban","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20250324","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1200\/JCO.2006.07.4799","article-title":"Early invasive cervical cancer:Tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651\/GOG 183 intergroup study","volume":"24","author":"Mitchell","year":"2006","journal-title":"J Clin Oncol"},{"key":"R10-20250324","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I):Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"R11-20250324","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II):Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"R12-20250324","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.ijrobp.2004.04.032","article-title":"Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma:Report from image-guided brachytherapy working group","volume":"60","author":"Nag","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20250324","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2010.06.004","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group:Considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy","volume":"96","author":"Hellebust","year":"2010","journal-title":"Radiother Oncol"},{"key":"R14-20250324","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.radonc.2011.12.024","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group (IV):Basic principles and parameters for MR imaging within the frame of image based adaptive cervix cancer brachytherapy","volume":"103","author":"Dimopoulos","year":"2012","journal-title":"Radiother Oncol"},{"key":"R15-20250324","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2016.05.014","article-title":"Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer","volume":"120","author":"Tanderup","year":"2016","journal-title":"Radiother Oncol"},{"key":"R16-20250324","first-page":"131","article-title":"Is the tandem and ring applicator a suitable alternative to the high dose rate selectron tandem and ovoid applicator?","volume":"16","author":"Erickson","year":"2000","journal-title":"J Brachyther Int"}],"container-title":["Journal of Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_171_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:42:57Z","timestamp":1787773377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_171_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jmp.jmp_171_24","relation":{},"ISSN":["0971-6203","1998-3913"],"issn-type":[{"value":"0971-6203","type":"print"},{"value":"1998-3913","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-10-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}